⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

August 1, 2024Open Access

Supplementary Figure S13 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy

Pei Y. Teo Youngrock Jung David H. Quach Joanna Koh Richard Ong Angeline Goh Alrina Tan Chee H. Ng Cheah C. Seh Kar Wai Tan Ivan D. Horak Lionel Low

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure S13. CD30 expression on HLADKO NALM6-CD30 cells obtained from peripheral blood of tumor-bearing mice at indicated time points. The lines with error bars indicate mean + SD.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Teo et al. (2024) studied this question.

synapsesocial.com/papers/68e5e0e0b6db643587574f55 https://doi.org/10.1158/2326-6066.26422799

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S13 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
2Supplementary Figure S17 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
3Supplementary Figure S17 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
4Supplementary Figure S16 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
5Supplementary Figure S16 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
6Supplementary Figure S7 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
7Supplementary Figure S7 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
8Supplementary Figure S11 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024